Trial Profile
Effects of levetiracetam on chronic neuropathic pain following spinal cord injury: a randomized, double-blind, placebo-controlled, cross-over, multi-center study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Levetiracetam (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- 25 Aug 2009 Actual number of patients (36) added as reported by ClinicalTrials.gov.
- 25 Aug 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
- 25 Aug 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.